Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination

(2010) Dominique Elias et al.   ANNALS OF SURGERY

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases

(2010) C. Q. Cao et al.   BRITISH JOURNAL OF SURGERY

Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

(2010) Jonathan Strosberg   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience

(2009) S Scigliano et al.   ENDOCRINE-RELATED CANCER

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

(2008) Julie King et al.   CANCER

Plasma Chromogranin A as Marker for Survival in Patients With Metastatic Endocrine Gastroenteropancreatic Tumors

(2008) R ARNOLD et al.   Clinical Gastroenterology and Hepatology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Surgery and Radiofrequency Ablation for Treatment of Liver Metastases from Midgut and Foregut Carcinoids and Endocrine Pancreatic Tumors

(2008) John Eriksson et al.   WORLD JOURNAL OF SURGERY